Przejdź do głównej treści

Widok zawartości stron Widok zawartości stron

News

Nawigacja okruszkowa Nawigacja okruszkowa

Widok zawartości stron Widok zawartości stron

JU MCB researchers develop a protein nanocapsule capable of delivering drugs to cells

JU MCB researchers develop a protein nanocapsule capable of delivering drugs to cells

In a breakthrough piece of research, scientists from the Jagiellonian University Małopolska Centre of Biotechnology have developed a tiny, hollow protein sphere, termed a “nanocage”, placed another protein inside it, and delivered both to cells. This achievement is considered an important step towards the development of controllable nanoscale drug delivery systems.

Drugs are becoming more complex; what were once simple small molecules are increasingly sophisticated functional biomacromolecules such as RNA and proteins. Being large and often quite fragile they offer a challenge for delivery to cells in the body where harsh conditions could disrupt them before they reach their target. Therefore, encapsulating them in a stable, protective container that can keep them in a pristine state until they reach their desired point of action would be very useful. This is especially true if the protective container can then open to release the drug where needed. This is what the new work has demonstrated.

The researchers, based at the laboratory of Professor Jonathan Heddle at the Małopolska Centre of Biotechnology of the Jagiellonian University, used an artificial protein cage called “TRAP-cage”, which they had previously developed. The TRAP-cage is around 21 nanometres in diameter and incredibly stable but opens up in response to conditions similar to those found in cells. In the new publication in the Biomacromolecules journal, the team, including lead authors Dr Antonina Naskalska and Dr Kinga Borzęcka-Solarz, showed that a protein called green fluorescent protein (GFP) could be placed inside the TRAP-cage. They then added molecules on the outside of the cage to give it the ability to penetrate cells. Using a microscope, they were able to observe it entering cells and freeing its cargo.

"The fact that the cage is highly stable but appears to open only in the cytoplasm of the cell, releasing cargo, is something very appealing for potential applications in drug delivery, ” commented Professor Heddle, who hopes that the work could be the foundation for producing new kinds of cages and the first step towards developing a form of programmable biological matter.

For more information about the Heddle lab, visit its website:: www.heddlelab.org

Cross-section of the cage with its GFP cargo entering cells

The above image shows a cross-section of the cage (gold) with its GFP cargo (green) entering cells (grey).

Diagram showing how the nanocapsule works

Polecamy również
Researchers list 10 most promising drugs for COVID-19 treatment
Researchers list 10 most promising drugs for COVID-19 treatment
JU-developed hybrid materials to combat osteoporosis
JU-developed hybrid materials to combat osteoporosis
Jagiellonian University signs an agreement with the international research centre FAIR
Jagiellonian University signs an agreement with the international research centre FAIR
Prof. Wojciech Żurek becomes a JU honorary doctor
Prof. Wojciech Żurek becomes a JU honorary doctor

Widok zawartości stron Widok zawartości stron

Find us at